Trends in vitamin, mineral and dietary supplement use in Switzerland. The CoLaus study P Marques-Vidal, P Vollenweider and G Waeber BACKGROUND/OBJECTIVES: Vitamin/mineral (VMS) and dietary supplements (DS) use is common in Switzerland, but nothing is known regarding the factors associated with their initiation, discontinuation or continuation of intake. SUBJECTS/METHODS: Prospective study conducted between 2003-2006 and 2009-2012 in Lausanne, Switzerland among 4676 participants (2525 women, age range 35-75 years). VMS were defined as single or multivitamin/multimineral preparations; DS were defined as any dietary supplement. RESULTS: VMS use was 20.6% at baseline and 20.3% at follow-up (P = 0.69): 559 (12.0%) participants discontinued; 545 (11.7%) initiated and 404 (8.6%) continued VMS use. On multivariable analysis, men had a lower relative risk ratio (RRR) of discontinuing, initiation or continuing; older age and being physically active were associated with a higher RRR of initiation or continuing; lower education and higher body mass index were associated with a lower RRR of discontinuing or continuing of VMS. DS use decreased from 10.4 to 6.8% (P o 0.001): 405 (8.7%) participants discontinued; 239 (5.1%) initiated and 81 (1.7%) continued DS use. On multivariable analysis, men had a lower RRR of discontinuing, initiation or continuing; older age had a higher RRR of initiation, discontinuing or continuing; being physically active was associated with a higher RRR of initiation or continuing; Swiss citizens and former smokers had a higher RRR of discontinuing. CONCLUSIONS: VMS use is stable in the Lausanne population, whereas DS use appears to be decreasing. Individuals can be categorized either as users or non-users depending on the study period, and consistent users are only a small fraction of prevalent users.
INTRODUCTION
Vitamin and mineral supplements (VMS) are taken by a significant fraction of the general population, [1] [2] [3] [4] [5] although their health benefits are questionable. [6] [7] [8] If some VMS might be of interest (that is, iron for anaemia and calcium/vitamin D for osteoporosis), several studies suggested that VMS either have no effect 9 or even increase total mortality. 10 Still, despite recommendations against the use of specific vitamins to prevent disease, 11 the prevalence of VMS use is increasing in Europe and the USA. [12] [13] [14] Interestingly, VMS and dietary supplements (DS) use appears to be a fairly unstable behaviour in the general population, with high rates of initiation or discontinuing. 15 Several socio-demographic characteristics such as female gender, older age and lower body mass index have been shown to be associated with consistent VMS use, 15 but the number of studies that assessed trends and determinants of VMS and DS use are relatively scarce. 15, 16 In a previous study, we showed that a sizable fraction of the Lausanne population consumed VMS or DS. 17 We now assessed trends in VMS and DS use and the factors associated with initiation, discontinuing and persistence of in VMS and DS use in the population of Lausanne, Switzerland.
MATERIALS AND METHODS Sampling
The CoLaus Study is a prospective study aiming to assess the prevalence of cardiovascular risk factors and to identify new molecular determinants of these risk factors in the population of the city of Lausanne, Switzerland. The sampling procedure of the CoLaus Study has been described previously. 18 In summary, a simple, non-stratified random sample of the overall population of Lausanne was drawn. The following inclusion criteria were applied: (a) written informed consent and (b) willingness to take part in the examination and to provide blood samples. Recruitment began in June 2003 and ended in May 2006 and included 6184 Caucasian participants. The evaluation included an interview, a physical exam, blood sampling and a set of questionnaires. The follow-up was performed between April 2009 and September 2012, 5 and a half years on average after the collection of baseline data and was similar to the baseline evaluation.
VMS and DS
VMS were defined as previously. 17 VMS and DS, including omega-3 supplements, were identified. Specific combinations of calcium and vitamin D were also identified.
For each group (VMS and DS) users were categorized as never (absent at baseline and follow-up), initiators (absent at baseline but present at follow-up), discontinuers (present at baseline but absent at follow-up) and continuers (present at baseline and follow-up) as performed in other studies conducted in antihypertensive drug treatment. 19, 20 In the prospective survey, drugs prescribed by a doctor were differentiated from those bought over-the-counter. As calcium+vitamin D supplements might be prescribed for osteoporosis prevention and iron ± vitamin B 12 for anaemia, sensitivity analyses were carried excluding participants taking such combinations. Also for sensitivity analyses, participants were categorized as never, inconsistent (initiators or discontinuers) or consistent (continuers) users, as performed previously.
Other data
Educational level was categorized into mandatory school, apprenticeship, high school and university. Marital status was categorized into single/ divorced/widowed and married/cohabitating. Country of birth was categorized into Swiss-born and born in another country. Smoking status was defined as never, former and current. A participant was considered as physically active if he/she practiced at least twice per week leisure-time physical activities with a minimal duration of 20 min.
As presence of cardiovascular risk factors has been associated with initiation or maintenance of VMS, 15 awareness of hypertension, dyslipidemia or diabetes was considered if the participant responded positively to the questions 'did a doctor tell you that you were hypertensive/had high cholesterol levels/were diabetic?' respectively. No data were collected regarding other diseases such as arthrosis, cancer or osteoporosis.
Body weight and height were measured with participants standing without shoes in light indoor clothes. Body weight was measured in kilograms to the nearest 100 g using a Seca scale, which was calibrated regularly. Height was measured to the nearest 5 mm using a Seca height gauge. Overweight was defined as body mass index (BMI) ⩾ 25 and o30 kg/m 2 and obesity as BMI ⩾ 30 kg/m 2 . As the number of underweight (BMIo18.5 kg/m 2 ) participants was very small (N = 83 or 1.8% of the total sample), they were included in a 'normal+underweight' category.
Statistical analysis
Participants were excluded if (a) they did not participate in the follow-up survey and (b) they had any missing socio-demographic data. Statistical analyses were performed using Stata version 13.1 for windows (Stata Corp, College Station, TX, USA). Descriptive results were expressed as number of participants (percentage) or as mean ± s.d. Bivariate analyses were performed using χ 2 for categorical variables and Student's t-test or analysis of variance for continuous variables. For continuous variables, post hoc pairwise comparisons using the method of Scheffe were performed when the results of the analysis of variance were statistically significant. In agreement with a previous study, 15 multivariable analysis was performed with multinomial logistic regression using never users as the reference; the results were expressed as relative risk ratio (RRR) and 95% confidence interval. Multi-collinearity of the dependent variables was tested using the collin function of Stata; variance inflation factors between 1.01 and 1.20 were obtained, suggesting that multi-collinearity was not present. Tests were two-sided and statistical significance was assessed for Po0.05.
Ethics statement
The CoLaus study was approved by the Institutional Ethics Committee of the University of Lausanne. The study was conducted according to the Declaration of Helsinki and all participants provided written informed consent prior to participating.
RESULTS

Selection procedure and characteristics of participants
Of the initial 6184 participants at baseline, 1501 (24.3%) did not participate in the follow-up survey and 7 (0.1%) had missing sociodemographic data. The selection procedure is summarised in Figure 1 and the comparison between included and excluded participants is summarised in Supplementary Table 1. Excluded participants were older, less frequently women, had a lower educational level, were less frequently born in Switzerland, were more frequently smokers, sedentary or obese and had a higher prevalence of self-reported hypertension and diabetes than included participants. Prevalence of VMS and DS use was also lower among excluded participants (Supplementary Table 1 ).
Trends and determinants of VMS use Prevalence of VMS use was 20.6% at baseline and 20.3% at followup (P = 0.69). During the 5.5-year study period, 559 (12.0%) participants discontinued; 545 (11.7%) initiated and 404 (8.6%) continued VMS use, whereas 3168 (67.8%) did not use any VMS at baseline and follow-up.
The bivariate associations between socio-demographic and clinical factors and being never using, initiating, discontinuing or continuing VMS are summarised in Supplementary Table 2 . Significant associations were found with gender, age, educational level, marital status, being born in Switzerland, physical activity and BMI categories. These associations were partly confirmed by multivariate analysis, the results of which are summarised in Table 1 . Men had a lower RRR of discontinuing, initiating or continuing VMS use. Older age and being physically active were associated with a higher RRR of initiating and continuing VMS use. Having a lower education or a higher BMI was associated with a lower RRR of discontinuing and continuing VMS use. Finally, presence of reported dyslipidemia was associated with a higher RRR of continuing VMS use (Table 1) . Similar findings were obtained when the analysis was split by gender (not shown).
Trends and determinants of DS use Prevalence of DS use was 10.4% at baseline and decreased to 6.8% at follow-up (P o 0.001). During the 5.5-year study period, 405 (8.7%) participants discontinued; 239 (5.1%) initiated and 81 (1.7%) continued DS use, whereas 3951 (84.5%) did not use any DS at baseline and follow-up.
The bivariate associations between socio-demographic and clinical factors and being never using, initiating, discontinuing or continuing DS are summarised in Supplementary Table 3 . Significant associations were found with gender, age, marital status, being born in Switzerland, smoking status, physical activity and BMI categories. These associations were partly confirmed by multivariate analysis, the results of which are summarised in Table 2 . Men had a lower RRR of discontinuing, initiating or continuing DS use. Older age was associated with a higher RRR of initiating, discontinuing and continuing DS use. Being physically active was associated with a higher RRR of initiating and continuing DS use. Being born in Switzerland and being former smoker were associated with a higher RRR of discontinuing DS use (Table 2 ). Similar findings were obtained when the analysis was split by gender (not shown).
Sensitivity analyses
The results of the sensitivity analysis on VMS use excluding calcium + vitamin D or iron ± vitamin B 12 combinations were similar to those obtained when the analysis included all VMS, except that some associations were no longer significant owing to smaller sample sizes (not shown).
The results of the sensitivity analysis on never, inconsistent (initiating or discontinuing) and consistent (continuing) use of VMS are summarised in Supplementary Tables 4 and 5 . On bivariate analysis, inconsistent use of VMS was associated with age, BMI, gender, educational level, marital and physical activity Table 4 ). Multivariate analysis showed that participants of male gender, lower education, married or obese had a lower RRR of inconsistent users, whereas older or physically active participants had a higher RRR of inconsistent use (Supplementary Table 5 ). Similar findings were obtained when the analysis was split by gender (not shown).
The results of the sensitivity analysis on never, inconsistent (initiating or discontinuing) and consistent (continuing) use of DS are summarised in Supplementary Tables 6 and 7 . On bivariate analysis, inconsistent use of DS was associated with age, BMI, gender, educational level, being born in Switzerland, smoking, marital and physical activity status (Supplementary Table 6 ). Multivariate analysis showed that participants of male gender or of lower education had a lower RRR of inconsistent use, whereas older, former smoker or physically active participants had a higher RRR of inconsistent use (Supplementary Table 7 ). Similar findings were obtained when the analysis was split by gender (not shown).
DISCUSSION
Individual VMS use changes with time. Conversely, the number of VMS users in the population remained stable during the 5.5 year period, the number of discontinuers being replaced by an almost equal number initiators. Conversely, the prevalence of DS use decreased significantly.
Trends and determinants of VMS use Several cross-sectional and prospective studies have shown an increase in VMS use in the general population or in specific groups. In this study, VMS was relatively stable, the large number of participants discontinuing being compensated by an almost similar number of participants initiating VMS use. Interestingly, a large fraction of initiators was due to calcium + vitamin D combinations and not to generic VMS, suggesting that this increase was medically driven. These findings are partly in agreement with a previous study, 15 with the difference that in the previous study the number of participants initiating VMS outweighed the number of participants discontinuing. Overall, our results indicate that individuals can be categorized either as VMS users or never users depending on the study period, and that VMS continuers are only a small fraction of prevalent VMS users.
Women and older age were significantly associated with both initiating and continuing VMS use, a finding in agreement with the literature. 15 A first explanation is that women and elderly people tend to be more health-conscious and to adopt health-promoting behaviours such as VMS use. Another explanation is the prevention of osteoporosis in elderly women by calcium + vitamin D combinations. Indeed, among women, 273 (10.9% of all women, 71.6% of all women initiators) initiated the calcium + vitamin D combination, versus 63 (2.5% of all women, 11.3% of all women discontinuers) who discontinued. Thus, and in agreement with another study, 16 our results suggest that most women VMS initiators did so for a medical and not for a personal reason.
Being physically active was associated with both the initiation and the continuation of VMS, a finding also reported elsewhere. 15 Physically active people tend to be more health-conscious and to adopt more frequently healthy eating and VMS use. 21 Whether physically active people initiated VMS to promote their health or to improve physical performance remains to be assessed. Abbreviation: BMI, body mass index. Results are expressed as relative risk ratio and (95% confidence interval). Statistical analysis by multinomial logistic regression using never users as reference. *P o0.05; **Po0.01; ***P o0.001.
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In the sensitivity analyses, participants of lower education had a lower RRR of inconsistent (initiating or discontinuing) or consistent (continuing) VMS use, a finding partly in agreement with a previous study, 15 where such associations were found in men only. Interestingly, when inconsistent users were split into initiators and discontinuers, the association with education was for discontinuing VMS only. The lower likelihood of discontinuing VMS among lesseducated people might be explained by the fact that participants with higher education consume more non-prescribed medicines, 22 and thus change consumption more frequently.
Presence of disease has been shown to increase the initiation of VMS by patients, 15 although this statement has been challenged. 23 Still, in this study, no consistent associations were found between self-reported hypertension, dyslipidemic or diabetic status and initiation of VMS. Interestingly, participants who reported dyslipidemia had a higher RRR of continuing VMS, a finding also reported elsewhere. 15 Although some studies have shown a small effect of VMS on lipid levels 24 or carotid atherosclerosis, 25 still VMS use is not recommended for the primary prevention of cardiovascular disease.
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Trends and determinants of DS use Contrary to a study conducted in the United States 16 but in agreement with another conducted in Scandinavia, 26 the prevalence of DS users decreased. Possible explanations include the absence or low efficiency of DS [27] [28] [29] [30] and tighter regulations regarding their health claims. 31 Still, it would be of interest that the decrease observed in this study could be confirmed by other independent studies. As for VMS, our results suggest that only a small fraction of all DS users continuously consumes them. 15 A possible explanation is that people adopt DS based on their health promises, 32 then discontinue when these benefits are not met or when side effects occur. 33 Still, as the reasons for discontinuing were not collected, these explanations remain speculative. Also, the diversity of DS precluded any analysis of the associations between discontinuing DS and the type of DS used. Conversely, DS continuation could be due to the presence of an effect (or to the absence of adverse effects) of DS. Again, the reasons for continuation are unknown and it would be of interest that further studies focus on the reasons for initiating, continuing or discontinuing DS.
Former smokers were more likely to be discontinuers than never or current smokers. It is possible that former smokers initially used DS as aid to prevent smoking relapse or to prevent weight gain induced by quitting smoking, then quit DS owing to their relative inefficiency. 34, 35 Physical activity was associated with DS initiation, discontinuing and continuation. If the findings regarding initiation and continuation are in agreement with the literature, 15, 36, 37 the association of physical activity with DS discontinuing was unexpected. A possible explanation is that physically active participants initially relied on DS to boost their performances and discontinued if the DS did not met their expectations. As no information was collected regarding the reasons for discontinuing, this explanation should be confirmed in other studies.
Implications for public health nutrition Our findings have several implications for public health nutrition. First, they confirm that both VMS and DS use is an unstable behaviour and that a sizable fraction of discontinuers is replaced by initiators. Thus, the overall effect of VMS or DS use on health Trends in vitamin/mineral supplement use P Marques-Vidal et al outcomes might be considerably decreased. Indeed, our results may partly explain the lack of effect of VMS on mortality, 9 as VMS intake might not have been consistent throughout the study period. Finally, the 'cycling' of VMS or DS could also lead to the sporadic occurrence of side effects due to interactions of VMS or DS with prescribed drugs. 38 Study limitations This study has several limitations worth acknowledging. First, excluded participants differed significantly from the included ones. Thus, it is likely that our results are based on a more healthconscious sample than the general population and that the prevalence estimates for VMS and DS use might be overestimated. Still, our drop-out rate (24.4%) is comparable to the one of a previous study assessing trends in VMS use (23.1%). 15 Second, no data on duration or amount of VMS or DS use was collected; hence, it is possible that our estimates for the prevalence of continuers might be overestimated, as during the follow-up period some participants could have undergone several cycles of use/non-use of VMS or DS. Thus, future studies should consider the number and duration of use/non-use cycles when assessing VMS or DS use. Third, no information was collected regarding the type, intensity, duration and patterns of physical activity, and only the status of being physically active was collected; hence, it is likely that this assessment might be too weak to draw precise conclusions regarding the impact of physical activity on VMS or DS changes. Still, physical activity was significantly associated with initiation of VMS or DS, suggesting that even raw evaluations of physical activity status can be used in such studies. Fourth, changes in the baseline independent variables during follow-up (that is, age, educational level, BMI) were not taken into account in the multinomial logistic model; still, using time varying variables would preclude comparison with similar studies 15, 38 and could differ according to the criteria used to define change (that is, in BMI levels). 39 Finally, only data from Caucasian participants living in a Swiss city were available, and it is currently unknown if our findings apply to other ethnicities or to other countries; for instance, a prospective study conducted in UK women 40 showed a much higher frequency of consistent users (54% vs 8.6% in our study), whereas the frequency of inconsistent (initiation+disconti-nuation) users was comparable (25% vs 23.6% in our study). Thus, the prevalence of never users, initiators, discontinuers and continuers might not be comparable between countries. Still, as the factors associated with VMS and DS use appear to be independent of the cultural and ethnic context, 36, 37 they might be extrapolated to other countries.
CONCLUSION
In this population-based sample of the city of Lausanne, the prevalence of VMS use remained stable, but this apparent stability was due to high and comparable discontinuing and initiation rates. Conversely, DS use appears to be decreasing. Being physically active favours the initiation of VMS or DS, and older age favours the initiation of VMS.
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